Top Markets
#1 Wrapped One Wrapped One +14,737.38%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +2,972.21%
#3 DeFi Kingdoms DeFi Kingdoms +1,091.75%
#4 Black Phoenix Black Phoenix +334.12%
#5 aPriori aPriori +117.60%
#6 Bedrock Bedrock +71.13%
#7 Cysic Cysic +42.73%
#8 Prom Prom +38.17%
#9 COTI COTI +34.60%
#10 Playnance Playnance +34.46%
Coin of the day
Wrapped One Wrapped One
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Roche Holding AG Roche Holding AG

Roche Holding AG

RO
Rang in Aktien #40
Roche Holding AG is a global healthcare enterprise with dual focuses:... Roche Holding AG is a global healthcare enterprise with dual focuses: pharmaceuticals and diagnostics. The company maintains a significant presence in numerous countries, including its home base in Switzerland, alongside Germany, the United States, Austria, the Netherlands, the United Kingdom, France, Belgium, and various other international markets. Its pharmaceutical segment develops and supplies treatments for a wide spectrum of medical conditions, encompassing oncology, neuroscience, infectious diseases, immunology, cardiovascular and metabolic disorders, ophthalmology, and respiratory ailments, as well as specific therapies for anemia, dermatology, hemophilia, inflammatory and autoimmune conditions, and transplant patients. On the diagnostic front, Roche provides in vitro tests designed to identify various diseases like cancer, diabetes, COVID-19, hepatitis, and human papillomavirus, in addition to supplying crucial diagnostic instruments and reagents. The company was founded in Basel, Switzerland, in 1896.
Aktienkurs
$481.73
Marktkapitalisierung
$377.65B
Veränderung (1 Tag)
-0.96%
Veränderung (1 Jahr)
50.07%
Land
CH
Handel Roche Holding AG (RO)

Kategorie

Healthcare
P/S-Verhältnis für Roche Holding AG (RO)
P/S-Verhältnis zum February 2026 TTM: 4.66
Laut den neuesten Finanzberichten und dem Aktienkurs von Roche Holding AG beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 4.66. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für Roche Holding AG von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
14.97 221.37%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
6.31 35.42%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
7.06 51.47%
US
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
4.90 5.26%
US
Novartis AG Novartis AG
Novartis AG
NOVN.SW
5.52 18.51%
CH